Helix BioMedix, Inc.
HXBM
$7.18
-$0.01-0.14%
OTC PK
| 09/30/2012 | 06/30/2012 | ||||
|---|---|---|---|---|---|
| Revenue | -0.30% | -30.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.30% | -30.85% | |||
| Cost of Revenue | -17.81% | -21.48% | |||
| Gross Profit | 9.05% | -35.00% | |||
| SG&A Expenses | 18.72% | -13.98% | |||
| Depreciation & Amortization | 3.62% | -4.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.43% | -14.03% | |||
| Operating Income | -28.12% | -6.92% | |||
| Income Before Tax | -17.49% | -14.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.49% | -14.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.49% | -14.87% | |||
| EBIT | -28.12% | -6.92% | |||
| EBITDA | -29.06% | -7.44% | |||
| EPS Basic | -17.49% | -14.86% | |||
| Normalized Basic EPS | -18.13% | -15.38% | |||
| EPS Diluted | -17.49% | -14.86% | |||
| Normalized Diluted EPS | -18.13% | -15.38% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||